The Rogosin Institute — New York, New York

The Rogosin Institute is a clinical research site located in New York, New York, United States 10021.

Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

The Rogosin Institute has participated in 26 clinical trials with 5 currently active.

Therapeutic areas: Renal Insufficiency, Chronic, End Stage Renal Disease, End-Stage Renal Disease.

Sponsors: Abbott, The Rogosin Institute, Deka Research and Development.

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Rogosin Institute?

The Rogosin Institute has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Rogosin Institute conducted?

The Rogosin Institute has 26 clinical trials on record, with 5 currently active. Their work covers Renal Insufficiency, Chronic, End Stage Renal Disease, End-Stage Renal Disease.

Is The Rogosin Institute accredited by Crixeo Health?

Yes — The Rogosin Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about The Rogosin Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.